EUVIMEDEUVIMED entdecken
Crossref

Self‐Amplified Nanomedicine Enables Lysosomal Blockade to Potentiate Starvation Therapy of Pancreatic Ductal Adenocarcinoma

Mingjie Song, Ziru Zhang, Xuan Pan, Xiaoyu Yang, Fenglin Xu, Zhenning Ye, Jianping Zhou, Qifeng Zhong, Yang Ding iD, Huaqing Zhang

Advanced Materials · 2026

DOI: 10.1002/adma.202519523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Mingjie Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Lysosomes, Carcinoma, Pancreatic Ductal, Nanomedicine, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Ten Thousand Talents Program for Young Top-notch Talents, Natural Science Foundation Outstanding Youth Fund of Jiangsu Province, Jiangsu 333 High-level Talent Training Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Starvation therapy targeting the metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) holds great potential; however, analyses of clinical samples and orthotopic models reveal that its efficacy is undermined by lysosome‐mediated metabolic compensation. To disrupt this metabolic adaptability, we herein engineer a homotypic membrane‐camouflaged nanomedicine capable of hypoxia‐responsive cascade drug release and enhanced tumor accumulation. The resulting nanomedicine performs a hypoxia‐induced phase transition that first liberates glucose oxidase to intensify oxygen deprivation and subsequently triggers burst release of chloroquine. Such a design of self‐amplified relay drug release ensures effective starvation induction and precise lysosomal alkalization, thereby shutting down lysosome‐mediated nutrient recycling. In a xenograft orthotopic PDAC model, this nanomedicine achieves 9.75‐fold increase in tumor accumulation, robust tumor inhibition of 92.8%, and an elevated survival rate of 80% with favorable biosafety. Collectively, our findings highlight lysosomal disruption as a therapeutic lever to potentiate starvation therapy and provide a clinically actionable nanoplatform to enhance metabolic interventions for other metabolically vulnerable malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesCarcinoma, Pancreatic DuctalNanomedicinePancreatic NeoplasmsHumansAnimalsCell Line, TumorChloroquineMiceGlucose Oxidase

Stichwörter der Autor:innen

hypoxia‐responsivelysosome‐mediated metabolic compensationpancreatic ductal adenocarcinomaself‐amplified relay releasestarvation therapy

Substanzen

ChloroquineGlucose Oxidase

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
  • Department of Hepato-Biliary-Pancreatic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
  • Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Yang Ding

Förderung

  • National Ten Thousand Talents Program for Young Top-notch Talents
  • Natural Science Foundation Outstanding Youth Fund of Jiangsu Province
  • Jiangsu 333 High-level Talent Training Project
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • National Natural Science Foundation of China
  • Youth Elite Scientists Sponsorship Program by CAST
  • Zhejiang Provincial Natural Science Foundation of China under Grant
  • Research Project of Lingang National Laboratory

Zitieren

APA

Song, M., Zhang, Z., Pan, X., Yang, X., Xu, F., Ye, Z., Zhou, J., Zhong, Q., Ding, Y., & Zhang, H. (2026). Self‐Amplified Nanomedicine Enables Lysosomal Blockade to Potentiate Starvation Therapy of Pancreatic Ductal Adenocarcinoma. Advanced Materials. https://doi.org/10.1002/adma.202519523

Vancouver

Song M, Zhang Z, Pan X, Yang X, Xu F, Ye Z, et al. Self‐Amplified Nanomedicine Enables Lysosomal Blockade to Potentiate Starvation Therapy of Pancreatic Ductal Adenocarcinoma. Advanced Materials. 2026. doi:10.1002/adma.202519523

BibTeX
@article{Song2026,
  author = {Song, Mingjie and Zhang, Ziru and Pan, Xuan and Yang, Xiaoyu and Xu, Fenglin and Ye, Zhenning and Zhou, Jianping and Zhong, Qifeng and Ding, Yang and Zhang, Huaqing},
  title = {Self‐Amplified Nanomedicine Enables Lysosomal Blockade to Potentiate Starvation Therapy of Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202519523}
}
Kostenlos starten →